Our president – the current one, not the incoming presidential one – wants credit for COVID-19 vaccines.
And he deserves some credit. Some. And not all of it good.
Take for example the Trump administration’s decision to turn down additional doses of Pfizer’s coronavirus vaccine. Pfizer multiple times offered first dibs on the purchase of additional doses – to the tune of 100 million to 500 million doses over the 100 million the administration did order months ago as part of a $1.95 billion deal.
But our leaders said we didn’t need the extra ones.
Please bear in mind that the vaccine is two-dose treatment, meaning 100 million doses will vaccinate only 50 million Americans. The U.S. has a population of 331 million.
